Skip to main content
Top
Published in: AIDS and Behavior 5/2015

01-05-2015 | Original Paper

Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy

Authors: C. E. Newman, J. de Wit, A. Persson, M. Holt, S. Slavin, M. R. Kidd, J. J. Post, E. Wright, L. Mao

Published in: AIDS and Behavior | Issue 5/2015

Login to get access

Abstract

The use of antiretroviral therapy to prevent HIV transmission is now advocated in many settings, yet little research has documented the views of people with HIV. Semi-structured interviews were conducted in Australia between 2012 and 2014 with 27 HIV-positive people not using treatment at the time of interview. Thematic analysis of views on treatment-as-prevention found that while many participants recognised potential prevention benefits, only a minority was in support of initiating treatment solely to achieve those benefits. A range of uncertain or critical views were expressed regarding who would benefit, risk reduction, and changing treatment norms. Participants resisted responsibility narratives that implied treatment should be used for the public good, in favour of making considered decisions about their preferred approach to managing HIV. Engaging communities in dialogue and debate regarding the risks and benefits of treatment will be critical if this new prevention strategy is to engender public trust.
Literature
2.
go back to reference Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2002;2(8):487–93.CrossRefPubMed Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis. 2002;2(8):487–93.CrossRefPubMed
4.
go back to reference Rodger A, Bruun T, Cambiano V, et al. Abstract 153LB: HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. Conference on Retroviruses and Opportunistic Infections 2014. Boston, USA 2014. Rodger A, Bruun T, Cambiano V, et al. Abstract 153LB: HIV transmission risk through condomless sex if HIV+ partner on suppressive ART: PARTNER study. Conference on Retroviruses and Opportunistic Infections 2014. Boston, USA 2014.
5.
go back to reference Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13(5):459–64.CrossRefPubMed Miller WC, Powers KA, Smith MK, Cohen MS. Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis. 2013;13(5):459–64.CrossRefPubMed
7.
10.
go back to reference Mayer K, Beyrer C. WHO’s new HIV guidelines: opportunities and challenges. Lancet. 2013;382(9889):287–8.CrossRefPubMed Mayer K, Beyrer C. WHO’s new HIV guidelines: opportunities and challenges. Lancet. 2013;382(9889):287–8.CrossRefPubMed
17.
go back to reference Mao L, Adam P, Kippax S, et al. The evolving views and practices of antiretroviral treatment (ART) prescribers in Australia. Med J Aust [in press]. Mao L, Adam P, Kippax S, et al. The evolving views and practices of antiretroviral treatment (ART) prescribers in Australia. Med J Aust [in press].
18.
go back to reference Whittaker B. Transforming Australia’s HIV prevention and treatment efforts to achieve an AIDS-free generation: the United Nations Political Declaration on HIV/AIDS and the Melbourne Declaration ‘Action on HIV’. Sex Health. 2014;11(2):101–6.PubMed Whittaker B. Transforming Australia’s HIV prevention and treatment efforts to achieve an AIDS-free generation: the United Nations Political Declaration on HIV/AIDS and the Melbourne Declaration ‘Action on HIV’. Sex Health. 2014;11(2):101–6.PubMed
19.
go back to reference Kulkarni SP, Shah KR, Sarma KV, Mahajan AP. Clinical uncertainties, health service challenges, and ethical complexities of HIV ‘test-and-treat’: a systematic review. Am J Public Health. 2013;103(6):e14–23.CrossRefPubMed Kulkarni SP, Shah KR, Sarma KV, Mahajan AP. Clinical uncertainties, health service challenges, and ethical complexities of HIV ‘test-and-treat’: a systematic review. Am J Public Health. 2013;103(6):e14–23.CrossRefPubMed
20.
go back to reference Bassett MT, Brudney K. WHO’s new guidelines for antiretroviral treatment. Lancet. 2013;382(9907):1777–8.CrossRefPubMed Bassett MT, Brudney K. WHO’s new guidelines for antiretroviral treatment. Lancet. 2013;382(9907):1777–8.CrossRefPubMed
21.
go back to reference Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba ADM. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS. 2012;26(13):1585–98.CrossRefPubMedCentralPubMed Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba ADM. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS. 2012;26(13):1585–98.CrossRefPubMedCentralPubMed
22.
go back to reference Kippax S, Stephenson N. Beyond the distinction between biomedical and social dimensions of hiv prevention through the lens of a Social Public Health. Am J Public Health. 2012;102(5):789–99.CrossRefPubMedCentralPubMed Kippax S, Stephenson N. Beyond the distinction between biomedical and social dimensions of hiv prevention through the lens of a Social Public Health. Am J Public Health. 2012;102(5):789–99.CrossRefPubMedCentralPubMed
24.
go back to reference Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention—and social science. Lancet 2007;370(9581):10–11. Imrie J, Elford J, Kippax S, Hart GJ. Biomedical HIV prevention—and social science. Lancet 2007;370(9581):10–11.
25.
go back to reference Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioeth. 2013;13(2):63–9.CrossRefPubMed Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioeth. 2013;13(2):63–9.CrossRefPubMed
26.
go back to reference Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMedCentralPubMed Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.CrossRefPubMedCentralPubMed
27.
go back to reference Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11(2):166–70.PubMed Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11(2):166–70.PubMed
28.
go back to reference Holt M, Murphy D, Callander D, et al. HIV-negative and HIV-positive gay men’s attitudes to medicines, HIV treatments and antiretroviral-based prevention. AIDS Behav. 2013;17(6):2156–61.CrossRefPubMed Holt M, Murphy D, Callander D, et al. HIV-negative and HIV-positive gay men’s attitudes to medicines, HIV treatments and antiretroviral-based prevention. AIDS Behav. 2013;17(6):2156–61.CrossRefPubMed
29.
go back to reference Down I, Prestage G, Triffitt K, Brown G, Bradley J, Ellard J. Recently diagnosed gay men talk about HIV treatment decisions. Sex Health. 2014;11(2):200–6.PubMed Down I, Prestage G, Triffitt K, Brown G, Bradley J, Ellard J. Recently diagnosed gay men talk about HIV treatment decisions. Sex Health. 2014;11(2):200–6.PubMed
31.
go back to reference Colvin CJ, Robins S, Leavens J. Grounding ‘responsibilisation talk’: masculinities, citizenship and HIV in Cape Town, South Africa. J Dev Stud. 2010;46(7):1179–95.CrossRefPubMed Colvin CJ, Robins S, Leavens J. Grounding ‘responsibilisation talk’: masculinities, citizenship and HIV in Cape Town, South Africa. J Dev Stud. 2010;46(7):1179–95.CrossRefPubMed
32.
go back to reference Beckmann N. Responding to medical crises: AIDS treatment, responsibilisation and the logic of choice. Anthrop Med. 2013;20(2):160–74.CrossRef Beckmann N. Responding to medical crises: AIDS treatment, responsibilisation and the logic of choice. Anthrop Med. 2013;20(2):160–74.CrossRef
33.
go back to reference Petersen A, Davis M, Fraser S, Lindsay J. Healthy living and citizenship: an overview. Crit Publ Health. 2010;20(4):391–400.CrossRef Petersen A, Davis M, Fraser S, Lindsay J. Healthy living and citizenship: an overview. Crit Publ Health. 2010;20(4):391–400.CrossRef
34.
go back to reference Race K. The undetectable crisis: changing technologies of risk. Sexualities. 2001;4(2):167–189. Race K. The undetectable crisis: changing technologies of risk. Sexualities. 2001;4(2):167–189.
35.
go back to reference Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed
38.
go back to reference Newman CE, de Wit JBF, Crooks L, Reynolds RH, Canavan PG, Kidd MR. Challenges of providing HIV care in general practice. Aust J Prim Health [in press]. Newman CE, de Wit JBF, Crooks L, Reynolds RH, Canavan PG, Kidd MR. Challenges of providing HIV care in general practice. Aust J Prim Health [in press].
39.
go back to reference Bryman A. Social research methods. 4th ed. Oxford: Oxford University Press; 2012. Bryman A. Social research methods. 4th ed. Oxford: Oxford University Press; 2012.
41.
go back to reference Mishler EG. Patient stories, narratives of resistance and the ethics of humane care. Health. 2005;9(4):431–51.PubMed Mishler EG. Patient stories, narratives of resistance and the ethics of humane care. Health. 2005;9(4):431–51.PubMed
42.
go back to reference Collins S, Geffen N. Community views: balancing the public health benefits of earlier antiretroviral treatment with the implications for individual patients—perspectives from the community. Curr Opin HIV AIDS. 2014;9(1):4–10.CrossRefPubMed Collins S, Geffen N. Community views: balancing the public health benefits of earlier antiretroviral treatment with the implications for individual patients—perspectives from the community. Curr Opin HIV AIDS. 2014;9(1):4–10.CrossRefPubMed
44.
go back to reference Hirsch JS. Gender, sexuality, and antiretroviral therapy: using social science to enhance outcomes and inform secondary prevention strategies. AIDS. 2007;21:S21–9.CrossRefPubMed Hirsch JS. Gender, sexuality, and antiretroviral therapy: using social science to enhance outcomes and inform secondary prevention strategies. AIDS. 2007;21:S21–9.CrossRefPubMed
45.
go back to reference de Wit JBF, Adam P. Revolution or evolution: What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high income countries? In: Eaton LA, Kalichman SC, eds. Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives: Springer; 2014. pp. 181–204. de Wit JBF, Adam P. Revolution or evolution: What can approaches based on the use of antiretroviral drugs contribute to HIV prevention in gay communities in high income countries? In: Eaton LA, Kalichman SC, eds. Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives: Springer; 2014. pp. 181–204.
47.
go back to reference Newman C, Persson A, Ellard J. ‘We just don’t know’: ambivalence about treatment strategies in the Australian community-based HIV media. Health. 2006;10(2):191–210.PubMed Newman C, Persson A, Ellard J. ‘We just don’t know’: ambivalence about treatment strategies in the Australian community-based HIV media. Health. 2006;10(2):191–210.PubMed
Metadata
Title
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy
Authors
C. E. Newman
J. de Wit
A. Persson
M. Holt
S. Slavin
M. R. Kidd
J. J. Post
E. Wright
L. Mao
Publication date
01-05-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0959-9

Other articles of this Issue 5/2015

AIDS and Behavior 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.